|
(HealthNewsDigest.com) – AstraZeneca and Novartis reported earnings and set a cautious tone for drug makers this year, as they brace for painful patent expiries and price pressures from government austerity measures and U.S. health reforms. – The Source: Tough Rules at Novartis – Expiring Patents Threaten Drug Firms
http://online.wsj.com/article/SB10001424052748704721104576107210399104304.html?mod=djemHL_t
Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com
For advertising/promotion, email: [email protected] Or call toll free: 877- 634-9180